Adial Pharmaceuticals Inc (ADIL)
1.70
-0.09
(-5.03%)
USD |
NASDAQ |
May 03, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
Adial Pharmaceuticals Shareholders Equity (Quarterly): 4.084M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.084M |
| September 30, 2023 | 2.339M |
| June 30, 2023 | 3.317M |
| March 31, 2023 | 1.440M |
| December 31, 2022 | 3.276M |
| September 30, 2022 | 5.409M |
| June 30, 2022 | 7.961M |
| March 31, 2022 | 10.71M |
| December 31, 2021 | 3.508M |
| September 30, 2021 | 7.200M |
| June 30, 2021 | 4.829M |
| March 31, 2021 | 5.618M |
| December 31, 2020 | 3.986M |
| September 30, 2020 | 7.085M |
| Date | Value |
|---|---|
| June 30, 2020 | 8.793M |
| March 31, 2020 | 5.551M |
| December 31, 2019 | 7.141M |
| September 30, 2019 | 8.73M |
| June 30, 2019 | 10.06M |
| March 31, 2019 | 11.73M |
| December 31, 2018 | 4.441M |
| September 30, 2018 | 4.929M |
| June 30, 2018 | -1.294M |
| March 31, 2018 | -1.307M |
| December 31, 2017 | -0.9976M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | -0.1035M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.440M
Minimum
Mar 2023
10.71M
Maximum
Mar 2022
5.844M
Average
5.551M
Median
Mar 2020
Shareholders Equity (Quarterly) Benchmarks
| BioVie Inc | 7.491M |
| BioSig Technologies Inc | -2.913M |
| Precision BioSciences Inc | 18.86M |
| Humacyte Inc | 13.55M |
| Monogram Orthopaedics Inc | 13.40M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.737M |
| Total Liabilities (Quarterly) | 0.6531M |